Browsing by Subject "Public-private partnerships"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Foundations of youth sport complex development: commonly identified critical components for successful economic development
    (2015-05) Jinkins, Larry E.; Gladden, James M.; Cecil, Amanda K.; Pierce, David A.
    Indianapolis created a whole new city identity using sports development and sports tourism as the primary drivers of change in the 1960’s and 1970’s. Since then, other cities have adopted the philosophy of using sport as a catalyst to improve the economic conditions of the city. This same philosophy has seemingly trickled down to small cities across the United States in the form of youth travel sport complex development. The size of the youth travel sport segment has reportedly reached $7 billion by the National Association of Sports Commissions, resulting in the rapid development of youth sports complexes in small cities and towns. The size and scope of these facilities entering the segment range from 50 acres to as many as 400 contiguous acres costing millions of dollars. Additionally, the perceived economic impact accompanying the development of such facilities are often overinflated due to the diversity of methods used in market analyses, feasibility studies, economic impact analyses, cost-benefit analyses, and Turco’s triple-bottom-line analysis. A more systematic process is needed to assign key performance indicators and identify the critical components that will assist in the decision to enter the segment and at what capacity. This study is designed to identify the necessary critical components to reach the desired economic impacts associated with youth sport complex development. Qualitative constant comparative method of data analysis was utilized in identifying commonly identified critical components (CICC) believed to contribute to the success and sustainability of a youth sports complex.
  • Thumbnail Image
    Item
    Industry Support of Medical Research: Important Opportunity or Treacherous Pitfall?
    (Springer, 2016-02) Tierney, William M.; Meslin, Eric M.; Kroenke, Kurt; Department of Medicine, IU School of Medicine
    Pharmaceutical and device manufacturers fund more than half of the medical research in the U.S. Research funding by for-profit companies has increased over the past 20 years, while federal funding has declined. Research funding from for-profit medical companies is seen as tainted by many academicians because of potential biases and prior misbehavior by both investigators and companies. Yet NIH is encouraging partnerships between the public and private sectors to enhance scientific discovery. There are instances, such as methods for improving drug adherence and post-marketing drug surveillance, where the interests of academician researchers and industry could be aligned. We provide examples of ethically performed industry-funded research and a set of principles and benchmarks for ethically credible academic-industry partnerships that could allow academic researchers, for-profit companies, and the public to benefit.